Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)

NCT02180204 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Tenecteplase
DRUG: Alteplase

Sponsor

Reza Behrouz, DO